The development of a stroke clinical pathway: an experience in a medium-sized community hospital.
Patients with acute ischemic strokes were studied in a medium-sized community hospital in Mississippi. Studies were done before and after implementation of the stroke clinical care pathway with emphasis on the following clinical indicators: 1) performance of a brain CT scan, 2) the search for the etiology of the stroke, 3) whether the patient was treated emergently for hypertension, 4) the use of measures to prevent deep-vein thrombosis, and 5) prophylactic drug treatment against recurrent stroke after hospital discharge. Following application of the clinical pathway, there was a significant improvement in all the clinical indicators that were felt to require further attention and none had a setback. The length of hospital stay was decreased, and there was no significant increase in the hospital costs in the post-pathway study despite an increase in the number of diagnostic and therapeutic procedures performed. When applied properly, clinical pathways can effectively mobilize hospital resources, maximize quality of care, and at the same time minimize costs.
Wee
A S
AS
Department of Neurology, University of Mississippi Medical Center, Jackson, USA.
Cooper
W B
WB
Chatham
R K
RK
Cobb
A B
AB
Murphy
T
T
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D019091:Critical Pathways / Q000458:organization & administration*; D003952:Diagnostic Imaging / Q000379:methods*; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006764:Hospitals, Community / Q000592:standards*; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D008922:Mississippi; D012042:Registries; D020521:Stroke / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome
D000925:Anticoagulants